Alex Koglin, PhD brings exceptional leadership in biotechnology commercialization with a proven track record of successfully translating laboratory research into market-ready companies. His experience spans from policy development at the highest levels of government to building and exiting successful ventures.

Policy and Advisory Experience:

• Served in the Office of Science and Technology Policy at the White House, drafting Presidential Council of Advisors on Science and Technology recommendations on biotechnology matters

• Current board member of the New Mexico Bioscience Authority, appointed by Governor Michelle Lujan-Grisham

• Board member of Mercury Bio and sought-after speaker at prestigious industry events including MIT's Boston CEO events, The Swiss Biocenter's BioTech Day, and the World Vaccine Congress

Entrepreneurial Track Record:

• CEO and Co-founder of Nature's Toolbox (2015-2024), successfully commercializing technology from Los Alamos National Laboratory into a profitable bioscience company based in Rio Rancho, New Mexico

• Co-founder of Mined Therapeutics (2021-2022), raising over $10 million for long non-coding RNA therapeutics before successful acquisition

• Demonstrated expertise in navigating the complex path from breakthrough science to commercial application in the highly regulated bioscience sector

Scientific Foundation: Alex's journey began with groundbreaking research on protein conformational switches published in Science Magazine in 2006, garnering international attention including commentary from Nobel laureate Kurt Wüthrich. His work at Harvard Medical School resulted in back-to-back Nature publications and a patent licensed by New England Biolabs for anti-tumor antibody applications.